: ,

: ,

, 414

, () , .

1

Delirium

: ,

, , .

: ,

.

. :

( ) : ,, ,

Parkinson Lewy delirium:

2-3 QTc.450 ms >25%

/

2

. (, )

. :

,

, , (.. )

BZD

:

(.. EPS)

1. Guideline watch: Practice guideline for the treatment of patients with delirium,

APA practice guidelines, 2004

2. Practice guideline for the treatment of patients with delirium, APA practice guidelines, 1999

3. National Guidelines for Seniors Mental Health: The Assessment and Treatment of Delirium, Canadian Journal of Geriatrics Volume 9, Supplement 2, 2006 S35

4. Expert Consensus Guidelines forUsing Antipsychotic Agents in Older Patients, J Clin Psych, 2004; 65, suppl 2

3

: 1. 2. 3. , 4.

() ()

: , , , , , ,

()

12-24

.

.

.

,

6 ()

() ,

, 12-24

4

/ . . , , , , , .

. .

,

,

,

2-5

5 ( )

2 ( ) 6-8 , .

. .

: ,

, , , ,

,

5

2 ( ) 6-8 ,

.

1. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia, The World Journal of Biological Psychiatry, 2005; 6(3): 132_/191

2. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia, The World Journal of Biological Psychiatry, 2006; 7(1): 5_/40

3. NICE: Full national clinical guideline on core interventions in primary and secondary care, The Royal College of Psychiatrists & The British Psychological Society, 2003

4. Guideline watch (september 2009): practice guideline for the treatment of patients with schizophrenia, APA Practice guidelines

5. Practice guideline for the treatment of patients with schizophrenia, APA Practice guidelines 2004

6. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice European Neuropsychopharmacology (2009), 19, 520-532

7. ECNP consensus meeting. Negative, depressive and cognitive symptoms of schizophrenia. Nice, March 2004B , European Neuropsychopharmacology (2007) 17, 7077

6

: 1. (acute phase therapy) 2. (continuation phase therapy) 3. (maintenance phase therapy)

. : (.. , ,

)

. : SSRIs, SNRIS, , ,

. . 2 .

(20% ) , , .

. 4 :

: , :

7

. . . . . . . . . . . . . .

:

, / .

. 2

: , :

. .

( )

. : , , , .

.

. 2-4 : :

.

. . ,

6-12 .

.

(.. , )

.

8

.

, .

. : 6-9 . : . . , . . , . . , . . :

o ( 2 5 3 )

o , o o /

. o .

. : 2-3 . . : . . ,

9

1. Practice guideline for the Treatment of Patients With Major Depressive Disorder,

Third Edition, APA, October 2010

2. NICE: Depression:The treatment and management of depression in adults, 2009

3. World Federation of Societies of Biological Psychiatry (WFSBP)

Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary CareThe World Journal of Biological Psychiatry, 2007; 8(2): 67_104

4. Texas medication nalgorithm project, procedural manual, major depressive disorder algorithms, 2008

5. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. Journal of Affective Disorders 117 (2009) S1S2

10

,

.

,

.

( , )

. ( )

(..

: )

: , , (SIADH),

, >65. ,

11

:

o . o . o . o . o . - o .

( ): SSRIs, SNRIs, , , .

SSRIs SIADH

: 1/2 .

4 . 2 4 :

o . : 4 ( ), ,

o . : /

o . : ,

8 : ,

SSRIs cross tapering

12 ( 24)

2 ,

,

K

12

1. Practice guideline for the Treatment of Patients With Major Depressive Disorder,

Third Edition, APA, October 2010

2. NICE: Depression:The treatment and management of depression in adults, 2009

3. World Federation of Societies of Biological Psychiatry (WFSBP)

Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary CareThe World Journal of Biological Psychiatry, 2007; 8(2): 67_104

4. Texas medication nalgorithm project, procedural manual, major depressive disorder algorithms, 2008

5. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. Journal of Affective Disorders 117 (2009) S1S2

13

-

. / 1- 1 : - , , (, , , , ) - + (, , , , ) () . 1

, , , , , (, , ) .

2 ( 2 ): . , , . 1 . 1

3 ( 2-4 ): . 1 . 2 : - (, ) - (, ) - + - - +, + -

: - ,

14

: - , , , , , - +

6-12 . .

. 1- 1 : - , , - +SSRI , +SSRI, +

1 , , , , , , .

, , (, , )

, .

2 ( 4 ): . , , . 1

3 ( 4 ): . 1 . 2 : - + SSRI - , +

4- 3 ( 4 ): - , + -

15

- + , + , + - + SSRI + - : , , , , 1

: - -

12 4 .

. - 1 : - ( ), ( ), - , , , depot - + , depot,

(, )

1 , , , , , , , .

) / : , , , , ) : + (+ )

2 : - - +, +, +

16

- +, +, +

3 : - - - -3 -

: - : , ,

2 5 ( , , , , )

.

1. Goodwin GM & Consensus Group of the British Association for

Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: revised second editionrecommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 2009; 23(4): 346388.

2. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry. 2009; 10(2):85-116.

3. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Mller HJ, Kasper S; WFSBP Task Force On Treatment Guidelines For Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry. 2010 Mar;11(2):81-109.

4. Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O'Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Young AH, Alda M, Milev R, Vieta E, Calabrese JR, Berk M, Ha K, Kapczinski F. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009 May;11(3):225-55.

17

&

1- 1 : - SSRIs , , SNRIs , (, 2-4 ) -

(SSRIs, SNRIs) . 1

, , , , , .

2 ( 8-12 ): . . 1 . 2 : - - (, ) - -

: - (, ) - - - ( )

6-12 .

18

1. Baldwin DS, Waldman S, Allgulander C. Evidence-based pharmacological

treatment of generalized anxiety disorder. International Journal of Neuropsychopharmacology 2011 doi:10.1017/S1461145710001434.

2. Bandelow B, Johar J, Hollander E, Kasper S, Moller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders - First Revision. The World Journal of Biological Psychiatry, 2008; 9(4): 248-312.

3. Management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care (clinical guideline 22, amended). National Institute for Health and Clinical Excellence, 2007, UK.

19

1- 1 : - SSRIs (, , , , , ) (, , 2-4 o) - 2-4 1

, , , , , .

2 ( 8-12 ): . . 1 . 2 : - - (, , )

: - 1 2 (.. SSRI + ) - - - - 12-24 .

1. Practice guideline for the treatment of patients with Panic Disorder. American

Psychiatric Association, 2009, USA.

2. Bandelow B, Johar J, Hollander E, Kasper S, Moller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders- First Revision. The World Journal of Biological Psychiatry, 2008; 9(4): 248-312.

20

3. Management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care (clinical guideline 22, amended). National Institute for Health and Clinical Excellence, 2007, UK.

21

( )

1- 1 : - SSRIs (, , , , , ) (, 2-4 ) * 1 , , , , , .

2 ( 8-12 ): . . 1 . 2 : - - ()

: - 1 (.. SSRI + ) - () - - -

6-12 . Bandelow B, Johar J, Hollander E, Kasper S, Moller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders - First Revision. The World Journal of Biological Psychiatry, 2008; 9(4): 248-312.

22

1- 1 : - SSRIs (, , , , , ) ,

. 1

, , , , , .

2 ( 8-12 4-6 ): . 1 . (2 )

: - (, , , ) - SSRI + - , - -

12-24 .

1. Bandelow B, Johar J, Hollander E, Kasper S, Moller HJ. World Federation of

Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders First Revision. The World Journal of Biological Psychiatry, 2008; 9(4): 248-312.

2. Practice guideline for the treatment of patients with Obsessive-Compulsive Disorder. American Psychiatric Association, 2007, USA.

23

1 : - , , 1

, , , , .

2 : - - - -

3 : - , , , - , -

: - 1 2 - , ,

6-12 .

Bandelow B, Johar J, Hollander E, Kasper S, Moller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders- First Revision. The World Journal of Biological Psychiatry, 2008; 9(4): 248-312.